Egils Vjaters

2.3k total citations · 1 hit paper
51 papers, 1.4k citations indexed

About

Egils Vjaters is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Egils Vjaters has authored 51 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 18 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Oncology. Recurrent topics in Egils Vjaters's work include Prostate Cancer Treatment and Research (29 papers), Radiopharmaceutical Chemistry and Applications (17 papers) and Cancer Treatment and Pharmacology (9 papers). Egils Vjaters is often cited by papers focused on Prostate Cancer Treatment and Research (29 papers), Radiopharmaceutical Chemistry and Applications (17 papers) and Cancer Treatment and Pharmacology (9 papers). Egils Vjaters collaborates with scholars based in Latvia, Finland and France. Egils Vjaters's co-authors include Karim Fizazi, Amir Snapir, Teuvo L.J. Tammela, Neal D. Shore, Mindaugas Jievaltas, Albertas Ulys, Toni Sarapohja, B. Yа. Alekseev, Murilo Luz and S. Polyakov and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Egils Vjaters

47 papers receiving 1.3k citations

Hit Papers

Darolutamide in Nonmetastatic, Castration-Resistant Prost... 2019 2026 2021 2023 2019 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
    2019 579 citations Karim Fizazi, Neal D. Shore et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Egils Vjaters Latvia 14 999 388 345 244 227 51 1.4k
Maria De Santis Austria 9 1.2k 1.2× 253 0.7× 474 1.4× 201 0.8× 288 1.3× 25 1.4k
Marcello Tucci Italy 24 1.3k 1.3× 369 1.0× 593 1.7× 403 1.7× 748 3.3× 100 1.9k
Naoto Kamiya Japan 22 796 0.8× 203 0.5× 178 0.5× 359 1.5× 283 1.2× 87 1.4k
Consuelo Buttigliero Italy 23 1.0k 1.0× 397 1.0× 247 0.7× 411 1.7× 692 3.0× 91 1.7k
Edoardo Francini Italy 20 632 0.6× 291 0.8× 215 0.6× 210 0.9× 554 2.4× 73 1.2k
Stephen Harland United Kingdom 14 1.1k 1.1× 330 0.9× 509 1.5× 215 0.9× 320 1.4× 26 1.5k
Sead Crnalic Sweden 19 775 0.8× 363 0.9× 90 0.3× 412 1.7× 304 1.3× 42 1.4k
Georg Stüben Germany 20 624 0.6× 147 0.4× 155 0.4× 193 0.8× 488 2.1× 46 1.2k
Francesca Vignani Italy 14 509 0.5× 186 0.5× 163 0.5× 187 0.8× 263 1.2× 46 750
Neel Shah United States 12 827 0.8× 317 0.8× 136 0.4× 484 2.0× 232 1.0× 20 1.2k

Countries citing papers authored by Egils Vjaters

Since Specialization
Citations

This map shows the geographic impact of Egils Vjaters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egils Vjaters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egils Vjaters more than expected).

Fields of papers citing papers by Egils Vjaters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Egils Vjaters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egils Vjaters. The network helps show where Egils Vjaters may publish in the future.

Co-authorship network of co-authors of Egils Vjaters

This figure shows the co-authorship network connecting the top 25 collaborators of Egils Vjaters. A scholar is included among the top collaborators of Egils Vjaters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Egils Vjaters. Egils Vjaters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vjaters, Egils, et al.. (2025). Liquid Biopsy Based Bladder Cancer Diagnostic by Machine Learning. Diagnostics. 15(4). 492–492. 2 indexed citations
2.
Saad, Fred, et al.. (2025). Reply to: Inferior Control Arms in Prostate Cancer Trials: The ARANOTE Trial. Journal of Clinical Oncology. 43(11). 1394–1395. 1 indexed citations
3.
4.
Vjaters, Egils, et al.. (2024). Profiles of urinal exosomal miRNAs derived from bladder cancer. Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication. 77(3). 361–374. 1 indexed citations
5.
Trenti, Emanuela, Evi Comploj, Christine Mian, et al.. (2024). Prospective evaluation of the RT-PCR based urinary marker Bladder Epicheck® as a diagnostic tool in upper urinary tract tumor. Minerva Urology and Nephrology. 76(2). 195–202. 4 indexed citations
6.
Fizazi, Karim, Neal D. Shore, Matthew R. Smith, et al.. (2023). Efficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer with comorbidities and concomitant medications from the randomised phase 3 ARAMIS trial. European Journal of Cancer. 192. 113258–113258. 7 indexed citations
7.
Thellenberg‐Karlsson, Camilla, Egils Vjaters, Teuvo L.J. Tammela, et al.. (2022). A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases. European Journal of Cancer. 181. 198–207. 5 indexed citations
8.
Fizazi, Karim, Neal D. Shore, Matthew R. Smith, et al.. (2022). Efficacy and safety outcomes of darolutamide in patients with nonmetastatic castration-resistant prostate cancer with comorbidities and concomitant medications from ARAMIS.. Journal of Clinical Oncology. 40(6_suppl). 256–256. 2 indexed citations
9.
10.
D’Elia, Carolina, Christine Mian, Esther Hanspeter, et al.. (2021). Diagnostic value of Xpert® Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer: an update. Therapeutic Advances in Urology. 13. 2080218751–2080218751. 8 indexed citations
11.
Vjaters, Egils, et al.. (2020). The role of conventional urodynamic in diagnosing specific types of urinary incontinence in women. SHILAP Revista de lepidopterología. 46(2). 134–139. 3 indexed citations
12.
Trenti, Emanuela, Christine Mian, Christine Schwienbacher, et al.. (2020). Comparison of 2 new real‐time polymerase chain reaction–based urinary markers in the follow‐up of patients with non–muscle‐invasive bladder cancer. Cancer Cytopathology. 128(5). 341–347. 34 indexed citations
13.
14.
Parfejevs, Vadims, et al.. (2019). Differential binding cell-SELEX method to identify cell-specific aptamers using high-throughput sequencing. Scientific Reports. 9(1). 8142–8142. 26 indexed citations
15.
Peltola, Katriina, Petri Bono, Robert H. Jones, et al.. (2018). ODM-204, a Novel Dual Inhibitor of CYP17A1 and Androgen Receptor: Early Results from Phase I Dose Escalation in Men with Castration-resistant Prostate Cancer. European Urology Focus. 6(1). 63–70. 5 indexed citations
16.
Vjaters, Egils, et al.. (2018). First-in-man Safety and Efficacy of the ClearRing Implant for the Treatment of Benign Prostatic Hyperplasia. European Urology Focus. 6(1). 131–136. 9 indexed citations
17.
Wagenlehner, Flo ri an, J. W. Olivier van Till, J. G. A. Houbiers, et al.. (2017). Fatty Acid Amide Hydrolase Inhibitor Treatment in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: An Adaptive Double-blind, Randomized Controlled Trial. Urology. 103. 191–197. 38 indexed citations
18.
Vjaters, Egils, et al.. (2016). The Correlation of Urethral Pressure Profilometry Data in Women with Different Types of Urinary Incontinence. Urologia Internationalis. 97(2). 218–223. 5 indexed citations
19.
Albertella, Mark R., Paul M. Loadman, Philip H. Jones, et al.. (2008). Hypoxia-Selective Targeting by the Bioreductive Prodrug AQ4N in Patients with Solid Tumors: Results of a Phase I Study. Clinical Cancer Research. 14(4). 1096–1104. 98 indexed citations
20.
Vanags, Indulis, Aigars Pētersons, Velta Ose, et al.. (2003). Biomechanical properties of oesophagus wall under loading. Journal of Biomechanics. 36(9). 1387–1390. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria De Santis Breakdown of academic impact, for papers by Marcello Tucci Breakdown of academic impact, for papers by Naoto Kamiya Breakdown of academic impact, for papers by Consuelo Buttigliero Breakdown of academic impact, for papers by Edoardo Francini Breakdown of academic impact, for papers by Stephen Harland Breakdown of academic impact, for papers by Sead Crnalic Breakdown of academic impact, for papers by Georg Stüben Breakdown of academic impact, for papers by Francesca Vignani Breakdown of academic impact, for papers by Neel Shah
Rankless by CCL
2026